DOI: 10.1055/s-00000019

Fortschritte der Neurologie · Psychiatrie

Referenz

Etges T, Karolia K, Grint T. et al.
An observational postmarketing safety registry of patients in the UK, Germany, and Switzerland who have been prescribed Sativex(®) (THC:CBD, nabiximols) oromucosal spray.

Ther Clin Risk Manag 2016;
12: 1667-1675

Etges T, Karolia K, Grint T. et al.
An observational postmarketing safety registry of patients in the UK, Germany, and Switzerland who have been prescribed Sativex(®) (THC:CBD, nabiximols) oromucosal spray.

Ther Clin Risk Manag 2016;
12: 1667-1675

Bibliographische Angaben herunterladen

Suchen in:
Aufrufen in: